133 related articles for article (PubMed ID: 22460003)
1. Antipsychotic polypharmacy: a needle in a haystack?
López de Torre A; Lertxundi U; Hernández R; Medrano J
Gen Hosp Psychiatry; 2012; 34(4):423-32. PubMed ID: 22460003
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia.
Divac N; Jasović-Gasić M; Samardzić R; Lacković M; Prostran M
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1250-1. PubMed ID: 17960865
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic polypharmacy or monotherapy?
Gardos G
Neuropsychopharmacol Hung; 2005 Jun; 7(2):72-7. PubMed ID: 16167458
[TBL] [Abstract][Full Text] [Related]
6. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
[TBL] [Abstract][Full Text] [Related]
9. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
11. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
[TBL] [Abstract][Full Text] [Related]
12. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit.
Dolder CR; McKinsey J
J Psychiatr Pract; 2011 Sep; 17(5):368-74. PubMed ID: 21926533
[TBL] [Abstract][Full Text] [Related]
14. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
Wu YH; Lai CY; Chang YS
Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines.
Ranceva N; Ashraf W; Odelola D
J Clin Pharmacol; 2010 Jun; 50(6):699-704. PubMed ID: 20056801
[TBL] [Abstract][Full Text] [Related]
18. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
19. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
20. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]